Friedreich’s Ataxia

2022-09-15T21:20:30+00:00September 15th, 2022|

Location/s: Eatontown, NJ
Age Range: 18 and older
Gender: Male, Female
Stipend: $7,750 for participants and $6,000 for caregivers

Study Schedule:

One telehealth visit and home nurse visit, 17 day/16 night inpatient stay, followed by 5 outpatient follow-up visits every other day, and 5 day/ 4 night inpatient stay. Upon discharge, home nurse follow-up visits 7 days and 30 days after the last dose of study drug. Total study duration up to 86 days.

Individuals who have a genetically confirmed diagnosis of Friedreich’s ataxia are needed for a Phase 2 research study of an investigational drug that is designed to replace frataxin, the protein deficient in FA, in mitochondria of cells.

You may be eligible if you:

  • Are male or female 18 years of age or older
  • Are able to perform basic daily care, such as feeding yourself and personal hygiene, with minimal assistance
  • Can sit upright with thighs together and arms crossed without requiring support on more than 2 sides
  • Have genetically confirmed Friedreich’s ataxia, homozygous GAA repeat expansions, with repeat sizing
  • Weigh over 40kg (88 lbs)


Compensation for your time and travel per visit will be provided for qualified participants.


Click below to take our brief online questionnaire

Participate In This Study
Interested in Volunteering?
Sign Up Online, Call Or Email Us Today at
Online Sign Up or (212) 994-4567 or participate@clinilabs.com

4 Industrial Way West
2nd Floor Eatontown, NJ 07724

NEW YORK- Midtown Manhattan
330 W. 58th Street
Suite 509
New York, NY 10019

462 1st Avenue,
Building H, Suite 7 N
New York, NY 10016

Online Sign-Up